CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale See Remarks sold 9,200 shares at $10.74 ($98,788)
- 4 Open-market sale Vice President, Finance sold 553 shares at $10.74 ($5,938)
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 25,131 shares at $12.03 ($302,361)
- 4 Planned sale See Remarks sold 24,992 shares at $12.04 ($300,839)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Technology Officer sold 7,383 shares at $9.85 ($72,723)
- 144 Insider Sale of Securities
- 4 Option exercise See Remarks acquired 5,474 shares (option exercise)
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
Page 9 of 20 · 383 filings